Desirudin

In the US, Desirudin (desirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Deep Vein Thrombosis, Prophylaxis.

US matches:

• Desirudin


• Desirudin Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AE01

CAS registry number (Chemical Abstracts Service)

0120993-53-5

Chemical Formula

C287-H440-N80-O110-S6

Molecular Weight

6963

Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

Hirudin (Hirudo medicinalisisoform HV1), 63-desulfo-

Foreign Names

• Desirudinum (Latin)
• Desirudin (German)
• Désirudine (French)
• Desirudina (Spanish)

Generic Names

• Desirudin (OS: BAN, USAN)
• Désirudine (OS: DCF)
• 63-Desulfohirudin (IS: WHO)
• CGP 39393 (IS: Ciba-Geigy)

Brand Names

• Iprivask
  Aventis, United States



• Revasc
  Canyon, Luxembourg; Novartis, Slovakia; Sanofi-Aventis S.A.U., Spain

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.